Biostimulatory filler usage is rising globally with some sources citing year-on-year growth in the category of up to 15%. Pioneering Korean regenerative hybrid dermal biostimulator aesthetics brand, JUVELOOK has experienced significant growth in the UK & Ireland since its exclusive strategic partnership with parent company VAIM and leading medical aesthetics company Laboratoires Fillmed UK & Ireland was officially announced in June 2025.
Together, the companies are emphasising the importance of UK & Ireland practitioners sourcing JUVELOOK and JUVELOOK VOLUME (currently known as LENISNA) through Laboratoires Fillmed UK & Ireland as the authorised distributor in the region to ensure product authenticity and patient safety.
Dr. Scott Julian , Laboratoires Fillmed Business Unit Director (UK & Ireland) comments: “Safety must always come first in medical aesthetics, and at Fillmed UK & Ireland safety starts at the source. Our strategic partnership with VAIM as the exclusive distributor of Juvelook and Lenisna in our regions means that we can be confident that every vial we supply to qualified UK practitioners is genuine, traceable, and compliant. It also ensures the highest standards of medical education and after-sales support.
A safe, transparent supply chain isn’t just good practice, it’s the foundation of patient safety and professional integrity. We urge practitioners to join us in the fight against the unauthorised distribution of unofficial products, that could not only cause significant harm to patient safety, but also the professional integrity of our industry.”
FURTHER INFORMATION
Fillmed JUVELOOK
T: 0800 999 1685 (9am-5pm Mon-Fri)
E: info.uk@fillmed.com
www.ukfillmed.com
